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Intellectual disability (ID) and autism spectrumdisorders (ASDs) have in common alterations
in some brain circuits and brain abnormalities, such as synaptic transmission and dendritic
spines morphology. Recent studies have indicated a differential expression for speciﬁc
categories of genes as a cause for both types of disease, while an increasing number
of genes is recognized to produce both disorders. An example is the Fragile X mental
retardation gene 1 (FMR1), whose silencing causes the Fragile X syndrome, the most
common form of ID and autism, also characterized by physical hallmarks. Fragile X mental
retardation protein (FMRP), the protein encoded by FMR1, is an RNA-binding protein
with an important role in translational control. Among the interactors of FMRP, CYFIP1/2
(cytoplasmic FMRP interacting protein) proteins are good candidates for ID and autism,
on the bases of their genetic implication and functional properties, even if the precise
functional signiﬁcance of the CYFIP/FMRP interaction is not understood yet. CYFIP1 and
CYFIP2 represent a link between Rac1, theWAVE (WAS protein family member) complex
and FMRP, favoring the cross talk between actin polymerization and translational control.
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INTRODUCTION
Intellectual disability (ID) and autism spectrum disorders (ASD)
are a serious public health problem. The causes of ID and autism
are extremely heterogeneous, ranging from environmental to
genetic and even combinations of the two. Autism is a disorder
of neural development characterized by impaired social interac-
tion and communication and by restricted and repetitive behavior.
Signs all begin before a child is three years old. Autism is a perva-
sive developmental disorder (PDD) that involves severe deﬁcits in
a person’s ability to communicate and interact with others. Chil-
dren with autism often have trouble using their imagination, have
a limited range of interests, and may show repetitive patterns of
behavior or body movements. Different people with autism can
have very different symptoms, thus health care providers consider
autism as a “spectrum” disorder (ASD), a group of disorders with
similar features, including autistic disorder (also called “classic”
autism), Asperger syndrome and PDD not otherwise speciﬁed or
atypical autism. ASD is a very common disorder (prevalence of
1:1000 newborns). Worldwide, 2–3% of the population is affected
by mild to severe ID. The economic and social consequences of
this disorder are very important since the majority of people with
ID require long-term supportive care or service. New technolo-
gies allowed the identiﬁcation of many mutations in ID patients
affecting single genes. Thus, genetic alterations identiﬁed in ID are
fast expanding. It is interesting to underline that mutations in the
same gene can cause ID or ASD or both and interestingly more
than 80% of XLID (X-Linked Intellectual Disabilities) genes are
also cause of autism (Schwartz andNeri,2012; Brentani et al., 2013;
Murdoch and State, 2013). These two disorders have in common
alterations in some brain circuits and brain abnormalities, such as
synaptic transmission and dendritic spine morphology (Gilman
et al., 2011). Remarkably, even if both ID and ASD are heteroge-
neous in their genetic and molecular bases, recent studies have
indicated a signiﬁcant enrichment for speciﬁc categories of genes
as a cause for both types of disease, while an increasing number
of genes is recognized to produce both disorders. Search for genes
causing ID and ASD, as well as characterization of animal models
for these disorders, allows to better understand the physiopathol-
ogy of these diseases and to understand the functioning of the
brain. During the last few years huge efforts have been made by
many groups in this ﬁeld, that have indicated the involvement of
several categories of genes in these disorders, including genes regu-
lating axon outgrowth, synaptogenesis, cell–cell adhesion, GTPase
signaling and the actin cytoskeleton (Gilman et al., 2011;Voineagu
and Eapen, 2013). On the same track, also for ID common path-
ways seem to emerge (e.g., Rho-GTPase and other small GTPase
pathways, JNK and Ras signaling), even if the full picture is in
continuous evolution (Davidovic et al., 2011; Hashimoto et al.,
2011; Pavlowsky et al., 2012; Melko et al., 2013). The increasing
number of genes involved in ASD allowed the generation of net-
works of genes involved in this disease that are spatio-temporally
coexpressed (Willsey et al., 2013).
An example of disorder characterized by both ID and ASD
is the Fragile X syndrome (FXS), the most common form of
inherited ID (estimated prevalence of 1:4000 males and 1:8000
females) and also the most frequent known cause of autism
(Auerbach et al., 2011). Silencing of the FMR1 gene, encod-
ing the Fragile X mental retardation protein (FMRP), causes
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FXS. The clinical manifestations characterizing patients affected
by FXS include moderate to severe cognitive impairment, elon-
gated facial features, attention deﬁcit, hyperactivity, stereotypy,
seizure, impulsivity, sensory hyperarousal, anxiety, and autistic
behavior (Bardoni et al., 2000). In brain the major phenotype
of FXS patients and FXS animal models (mouse, Drosophila)
is the presence of dendritic spines that are longer, thinner and
denser than normal (Comery et al., 1997; Irwin et al., 2000, 2002;
Schenck et al., 2003). They represent the cellular defect under-
pinning the neuronal dysfunctions characterizing this disorder.
Interestingly, this morphological defect is associated to the alter-
ation of different forms of synaptic plasticity in mouse brain
(Dolen et al., 2010). FMRP is an RNA-binding protein that plays
a role in several steps of mRNA metabolism and, in particu-
lar, in translational control at the synaptic level. The absence
of FMRP may alter the processing, localization or translational
regulation of mRNAs encoding pre- and post-synaptic proteins.
These defects can account for the abnormal maturation of den-
dritic spines in FXS (Swanger and Bassell, 2011; Bardoni et al.,
2012;Maurin et al., 2014).The lack of FMRP interferes withmech-
anisms underlying metabotropic glutamate receptor (mGluR)
receptor-dependent long-term depression (LTD) – a prominent
form of synaptic plasticity (Huber et al., 2002) and epileptoge-
nesis (Chuang et al., 2005). Indeed, mGluR receptor-dependent
LTD in the hippocampus is ampliﬁed in the absence of FMRP,
whereas NMDA receptor-dependent LTD is not (Huber et al.,
2002). mGlu5 receptor-dependent long-term potentiation (LTP)
is instead reduced in the cerebral cortex of Fmr1 null mice (Wil-
son andCox, 2007). ThemGlu5 receptor-dependent LTD found in
animal models of FXS, unlike the one found in wild-type animals,
is insensitive to inhibitors of protein synthesis (Bureau et al., 2008).
One possibility is that the constitutive abnormality in the expres-
sion of synaptic proteins alters long-term responses to mGluR5
receptor activation in this syndrome. This data is consistent with
the increased internalization of AMPAR in FMRP-deﬁcient den-
drites in the basal state (Nakamoto et al., 2007). Moreover, it
is noteworthy that mGluR5 receptors are less associated to the
Homer protein in the brain of Fmr1 knockout mice, which is
suggestive of an important alteration in receptor signaling (Giuf-
frida et al., 2005). Hippocampal epileptogenesis is another form
of synaptic plasticity that depends on group I mGlu receptor acti-
vation and protein synthesis and is altered in Fmr1 null mice. The
increased excitability in the absence of FMRP can be reversibly
blockedby 2-methyl-6-(phenylethynyl)pyridine (MPEP) a speciﬁc
antagonist of mGluR5, suggesting elevated constitutive mGluR5
receptor activation in FXS. Fmr1 mutant mice with a 50% reduc-
tion in mGluR5 expression exhibited a rescued phenotype (Dolen
et al., 2010). However, other different pathways are controlled by
FMRP (Davidovic et al., 2011) and up to date is has been difﬁcult
to dissect signaling defects determining ID and signaling defects
relevant for autistic behavior. Two main paths however, seem to
emerge as a link between the two pathologies in FXS: one is rep-
resented by the correct balance of the mGluR signaling pathway
(Auerbach et al., 2011) and the other by the link with RhoGTPase
activity and actin remodeling, represented by the two cytoplasmic
FMRP interacting proteins CYFIP1 and CYFIP2 (Schenck et al.,
2001, 2003).
CYFIP PROTEINS: THE WAVE COMPLEX AND BEYOND
CYFIP1 and CYFIP2 (also known as PIR121) are members of
a gene family highly conserved during evolution (Schenck et al.,
2001). They are components of the canonical WAVE regulatory
complex (WRC) that, besides the WAVE protein (WAS protein
family member), also contains the NAP1 (NCKAP1 or HEM1
in hematopoietic cells) subunit, the ABI1 protein (or one of its
paralogous proteins, ABI2 or NESH) and BRK1 (also known as
HSPC300) (Cory and Ridley, 2002; Derivery et al., 2009). The
WAVE complex transduces Rac signaling via CYFIP1 to trig-
ger Arp2/3-dependent actin nucleation (Cory and Ridley, 2002;
Derivery et al., 2009). This process is important in the spatio-
temporal regulationof actin dynamics to get correct cellmigration,
cell polarity (in particular in neurons the axonal polarity), cell
adhesion and vesicle trafﬁcking. The WASP family (Wiskott–
Aldrich syndrome protein) is composed by ﬁve members: WASP,
N-WASP andWAVE1, 2, and 3. All these proteins are characterized
by the presence of a VCA (verprolin homology, central and acidic
region) domain able to activate the Arp2/3 complex. Indeed, as
shown in Figure 1, CYFIP1/2 interact with the small RhoGTPase
Rac1. Upon this binding the subcomplex CYFIP1/2, Nckap1/ABI1
leaves the inactive WAVE holo complex. While WAVE can now
interact with Arp2/3, the CYFIP1-containing subcomplex is avail-
able to interact with other proteins (Figure 1) and then also with
FMRP. Indeed, we have shown that the FMRP/CYFIP interac-
tion is GTP dependent (Schenck et al., 2001, 2003). Puriﬁed Rho
GTPase Rac1 can bind and activate recombinant WAVE complex
in vitro (Lebensohn and Kirschner, 2009) and the crystal structure
of the WAVE complex identiﬁed a potential binding site for Rac1
in CYFIP1(Chen et al., 2010). Interestingly it has also been shown
that WAVE complex activation is obtained by the cooperation of
the Arf and Rac1 GTPases (Koronakis et al., 2011).
Consistent with this function, the WAVE complex has been
shown to be involved in lamellipodia formation via the interac-
tion with clathrin heavy chain (CHC), a protein known to be
involved in membrane trafﬁcking. In this new role CHC recruits
theWAVE complex to the membrane, increasing the speed of pro-
trusion and cell migration (Gautier et al., 2011). Interestingly, this
mechanism is conserved from Drosophila until mammalian cells
(Kunda et al., 2003; Gautier et al., 2011). Moreover, in another
study it was shown that activated ARF1 (ADP-ribosylation factor
1) GTPase triggers the recruitement of AP-1 (Adaptor Protein-
1) and clathrin on the trans-Golgi network (TGN) membranes.
At the edges of the clathrin-, AP-1 coated subdomains also the
CYFIP,ABI,NAP1 complex is recruted. HIP1R binding to clathrin
light chains could prevent actin polymerization on the surface of
clathrin coats. In a second step, activated Rac1 binds to CYFIP
and activates the actin nucleation complex leading to N-WASP-
dependent activation of ARP2/3 and actin polymerization toward
the TGN membrane. This mechanism provides complementary
but independent levels of regulationduring early stages of clathrin-
AP1-coated carrier biogenesis. Thus theWAVE complex, or at least
a CYFIP-containing subcomplex, participates to different clathrin
functions (Anitei et al., 2010). Interestingly enough, inactivation
of CYFIP1 in MCF-10A (an immortalized but not transformed
mammary epithelial cell line able to form 3D acinar structures
in Matrigel) produced acini with abnormal structures while cells
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FIGURE 1 | Dynamics of CYFIP Proteins in the context of theWAVE complex and actin polymerization. (A) Structural organization of theWRC in the
Rac-GDP condition; (B) Structural organization of theWRC in the Rac-GTP condition.
expressing normal CYFIP1 levels display a normal morphology.
Knockdown of WAVE pathway components, Nckap1 and WAVE
2, generated phenotypes similar to those observed upon CYFIP1
silencing, while inactivation of FMR1 has no impact on cell mor-
phology. Furthermore, silencing of CYFIP1 interferes with normal
epithelial morphogenesis and cooperates with Ras to produce
invasive carcinomas in vivo (Silva et al., 2009). A proapoptotic role
was also proposed for CYFIP2 by interacting with the Insulin-like
growth factor 2 mRNA-binding protein-1 (IMP-1; Mongroo et al.,
2011).
Very recently, in ﬂy a new motif, named WIRS, was identi-
ﬁed deﬁning a new class of ligands of the WRC including ∼120
membrane proteins (e.g., protocadherins, ROBOs, netrin recep-
tors, neuroligins, GPCRs, and channels). The WIRS peptide
motif speciﬁcally interacts with the surface formed between Sra
(CYFIP1/2) and Abi2 (Ortholog of Abi1 and Abi3). In Drosophila
mutations altering this interaction result in the disruption of actin
cytoskeleton organization and egg morphology leading to female
sterility (Chen et al., 2014).
CYFIP1 and 2 are localized at the synapse and have been
described to interact with FMRP in a GTP-dependent manner.
Interestingly, while CYFIP1 interacts only with FMRP,CYFIP2was
also shown to interact with FXR1P and FXR2P, the two paralogs of
FMRPbelonging to the FXR (Fragile X related) genes family. These
two proteins share a high level of homology with FMRP and they
are supposed to have a similar function, probably partially com-
pensating for the absence of FMRP in FXS patients (Schenck et al.,
2001). CYFIP1/2 are not RNA-binding proteins and their function
is thought to modify some functional properties of FMRP. Indeed
the domain of CYFIP1/2 interaction with FMRP is the same that
mediates homo-heterodimeryzation of the FXR family (Schenck
et al., 2001). This suggested binding with CYFIP1/2 can interfere
with the ability of FMRP to dimerize with its paralogs FXR1P and
FXR2P. Alternatively, CYFIP1/2 could modify FMRP afﬁnity for
RNA. A role of CYFIP1 was also proposed as a component of the
translational initiation complex interacting with the FMRP/BC1
complex (Napoli et al., 2008). However, the in vivo and in vitro for-
mation of this complex is controversial (Iacoangeli et al., 2008a,b).
A recent study using double FMR1/BC1 KO mice has deﬁnitively
shown that FMRP and BC1 cannot belong to the same com-
plex even if they are likely to modulate common target RNAs
via independent mechanisms (Zhong et al., 2010). Furthermore,
since more than 80% of the FMRP pool is located on translat-
ing polyribosomes, the role of a putative CYFIP-FMRP containing
initiation complex in regulating initiation of translation is very
unlikely to have an impact on FMRP function (Corbin et al., 1997;
Feng et al., 1997; Khandjian et al., 2004; Stefani et al., 2004;Aschraﬁ
et al., 2005; Darnell et al., 2011). It is also important to underline
that the interaction of CYFIP1/2 via FMRP with polyribosomes
was shown, suggesting that CYFIP can also modulate the main
function of FMRP when it is associated to actively translating
polyribosomes (Schenck et al., 2001). In this context, the link
between membrane proteins and CYFIP recently described (Chen
et al., 2014) may represent an interesting FMRP-dependent regu-
lation of translation via external stimuli driven by CYFIP proteins
to actively translating polyribosomes.
CYFIP2 mRNA was also reported to be a target of FMRP,
that can modulate its expression (Darnell et al., 2011), creating
a double link between the two proteins. It is well known that
FMRPmodulates the expression of proteins that have an effect on
the cytoskeleton [e.g., MAP1B, PP2Ac, p0071 (Brown et al., 2001;
Castets et al., 2005; Nolze et al., 2013)] suggesting that the link
between CYFIP1/2 and the reorganization of the cytoskeleton is
two-fold: on one side via its participation to the WRC as a reg-
ulator of WAVE activity and on the other via its interaction with
FMRP.
In conclusion, CYFIP role in RNA metabolism through its
interaction with FMRP and/or other RNA-binding proteins, as
recently proposed (De Rubeis et al., 2013), should be better
determined by a large-scale study that is still lacking to date.
CYFIP ANIMAL MODELS
Drosophila
The link between CYFIP proteins and other protein/complexes
and in particular with the RhoGTPase pathway, pushed us to
develop an animal model in Drosophila allowing a ﬁrst analysis
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of the role of CYFIP in development/maturation of the ner-
vous system. We considered the ﬂy to be a simpliﬁed model
since only one homolog of the CYFIP family (dCYFIP) and only
one homolog of the FXR family (dFMR1) are present. dCY-
FIP is speciﬁcally expressed in the nervous system and interacts
biochemically and genetically with dFMR1 and dRac. dCYFIP
mutations affect axons (growth, guidance, branching) much
like mutations in dFMR1 and in Rho GTPase dRac1. CYFIP,
like the ﬂy FMRP and Rac1 orthologs, plays a pivotal role
in the establishment of neuronal connectivity (Schenck et al.,
2001). A similar phenotype has been validated for Cyﬁp2 (not
yet for Cyﬁp1) in zebraﬁsh (Pittman et al., 2010) and rat hip-
pocampal neurons (Kawano et al., 2005). Since neuromuscular
junctions (NMJs) share a number of features with central excita-
tory synapses in vertebrate brain and constitute the best known
synaptic plasticity model in Drosophila, we analyzed these struc-
tures in dCYFIP and dFMR1 mutant ﬂies. In dCYFIP mutants,
synapse terminals are shorter and display a higher number of
buds than in wild-type animals, indicative of impaired synapse
growth (Schenck et al., 2001). Loss of dFMR1 (Zhang et al.,
2001) produces a NMJ phenotype that is opposite to that of
dCYFIP null ﬂies, suggesting an opposite functional role for
these two proteins. Furthermore, a co-overexpression of dCYFIP
partly rescues the dFMR1 overexpression phenotype (e.g., short
synapses) suggesting that dCYFIP negatively controls dFMR1 at
the synapse. Finally, using the ﬂy eye to test for genetic inter-
actions, we could order the three molecules within a pathway
where dRac1 controls dCYFIP that, in turn, regulates dFMR1
(Schenck et al., 2003). Both the convergent phenotypes and
dosage experiments clearly indicated a molecular link between
dFMR1 and the Rho GTPases pathway in neuronal remodel-
ing. We speculated that CYFIP proteins may regulate dFMR
-mediated translational control. Regulation of NMJ develop-
ment by dCYFIP was conﬁrmed by the study of Zhao et al.
(2013) Furthermore, these authors performed a detailed analy-
sis of synapses of dCYFIP mutants. Using electron microscopy
they showed that synaptic vesicles (SVs) are larger in mutants.
While the number of SV was unchanged between mutants and
wild-type ﬂies, the number of cisternae was elevated in mutants.
These abnormalities suggest that dCYFIP may regulate endocyto-
sis and/or vesicle recycling by inhibiting F-actin assembly (Zhao
et al., 2013).
Interestingly, inactivation of Drosophila CYFIP resulted also
in the reduced expression of Kette (Nckap1) and Scar (WAVE)
as well as all the other members of the WAVE complex (Bogdan
et al., 2004; Schenck et al., 2004; Qurashi et al., 2007; De Rubeis
et al., 2013). Inactivation of each member of the WRC has been
shown to produce a similar phenotype, in Drosophila as well as
in cell lines, as it was was shown in HeLa cells (Gautier et al.,
2011), inMEF (Dubielecka et al., 2011) and, as alreadymentioned,
in MCF-10A cells (Silva et al., 2009). Collectively these ﬁndings
demonstrate the tight regulation of the expression of the mem-
bers of the WAVE complex that is conserved during evolution as
well as their function. In conclusion, silencing of each member of
the WAVE complex disrupts its function enabling actin polymer-
ization, lamellipodia formation, and cell migration (Eden et al.,
2002; Dang et al., 2013).
ZEBRAFISH
Observations in the ﬂy have been conﬁrmed in zebraﬁsh,
where two CYFIP genes are expressed. Pittman et al. (2010)
studied the function of Cyﬁp2 during eye and brain devel-
opment by analyzing a mutant (nevermind, also called nev)
isolated in a screen for mutations affecting retinotectal axon
pathﬁnding). These authors showed that Cyﬁp2 is required to
mantain positional information by dorsonasal axons as they
project through the optic tract and the tectum. The lamination
of the eye is disrupted in nev mutants, apparently indepen-
dently of the axon guidance phenotype. Interestingly, these
authors addressed the question of the redundancy between
Cyﬁp1 and Cyﬁp2, but they were unable to show any com-
pensation of Cyﬁp1 in the absence of Cyﬁp2 (Pittman et al.,
2010).
MOUSE
Cyﬁp1-null mouse are lethal at the ﬁrst steps of embryonic
development. Bozdagi et al. (2012) decided to analyze haploin-
sufﬁciency of Cyﬁp1. They observed that this condition mimics
key aspects of the phenotype of Fmr1 knockout mice. Indeed,
in Cyﬁp1 heterozygous mice mGluR-dependent LTD was signiﬁ-
cantly increased in comparison to wild-type mice. In Cyﬁp1+/−
mice mGluR-LTD was not affected in the presence of protein
synthesis inhibitor (Bozdagi et al., 2012). Unfortunately, these
authors did not analyze the presence of audiogenic seizures in
Cyﬁp1 +/− mice, which is the most relevant phenotype in
the FXS mouse model and is dependent on the exaggerated
activation of mGluR5. Indeed, this phenotype is rescued by treat-
ing mice with MPEP (2-Methyl-6-(phenylethynyl)pyridine) an
antagonist of mGluR5 (Musumeci et al., 2000; Yan et al., 2005;
Thomas et al., 2012). This experiment would be very impor-
tant to deﬁne common actions/pathways of CYFIP1 and FMRP
in neuronal function. Behaviorally, Cyﬁp1 heterozygous mice
showed enhanced extinction of inhibitory avoidance, similarly
to Fmr1 KO mouse, while no differences have been observed in
Y-maze and Morris water maze (to detect alterations in work-
ing memory and learning and memory ability, respectively;
Bozdagi et al., 2012). On the same track, the inactivation of
Cyﬁp1 in neurons by siRNA generates dendritic spines that are
similar to those observed by silencing Fmr1 (immature ﬁlopo-
dia) even if their number does not appear to be increased (De
Rubeis et al., 2013). However, these latter data are in contra-
diction with literature concerning the WAVE complex, since if
the increased level of immaturity of spines is observed by all
investigators, it appears that the reduced activity of the WAVE
complex results in a reduced number and length of spines.
Indeed, in agreement with previous studies in Drosophila NMJ
(Schenck et al., 2003, 2004; Bogdan et al., 2004; Qurashi et al.,
2007), cultured hippocampal neurons obtained frommice lacking
WAVE-1 display a 60% reduction of the extent of neurite out-
growth when compared with wild-type as well as 20% reduction
of dendritic spines density, and spines appear more immature
(Soderling et al., 2007). These mice display a reduced num-
ber (−30%) of post-synaptic spines in CA1 hippocampus and
these spines made abnormal synaptic contacts; furthermore,
the spine head was ﬂattened, with an abnormal content of
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internal membrane-bound structures (Hazai et al., 2013). In rat
hippocampal neurons, inactivation of WAVE or CYFIP1 resulted
in a reduced axonal outgrowth (Kawano et al., 2005), as pre-
viously shown in the ﬂy (Schenck et al., 2003). Surprisingly,
De Rubeis et al. (2013) do not comment on all discrepancies
observed between their results and the literature concerning actin
remodeling studies. Evenmore puzzlingly, they wrote“. . ...Active-
Rac1 promotes CYFIP1 recruitment to the WAVE complex and
thus actin polymerization.” Indeed, as already mentioned and
described by many authors, activated Rac induces the release
of CYFIP/NAP/ABI from the WAVE complex that at this point
becomes active since the WAVE complex is intrinsically inactive
(Cory and Ridley, 2002; Eden et al., 2002; Derivery et al., 2009;
Figure 1). In the model of De Rubeis et al. (2013) Rac acti-
vation should block the WAVE complex instead than activating
it!
At this stage we can only conclude that the function of this
protein is complex and its implication in different cell pathways is
not easy to study. Only in the future the generation of a conditional
mousemodel for CYFIP1/2will allow to answer tomany questions
concerning the role of this family of proteins (and the WRC in a
general manner) in neuronal morphology and maturation.
GENETICS OF CYFIP1 AND 2 GENES AND ASSOCIATED
GENETIC PATHOLOGIES
No point mutations associated to diseases have been described so
far in these genes but some indications concerning their impact
on human cognition and/or behavior are indicated by genetic
abnormalities. Human CYFIP1 is located in 15q13. Structural
abnormalities involving 15q11–q13 are relatively common and
many, but not all, of these rearrangements are associated with
an abnormal phenotype. Paternal deletions of this region result in
Prader–Willi syndrome (PWS) and maternal deletions in Angel-
man syndrome (AS), both characterized by ID (Cassidy et al.,
2000). Interstitial duplications of maternal origin that include
the critical region for PWS and AS (PWACR) produce a more
variable phenotype, distinct fromPWSandAS, that includes hypo-
tonia, ataxia, seizures, developmental delay and autism or atypical
autism with no or only minor dysmorphic features. Conversely,
paternal duplications of the PWACR are not associated with an
abnormal phenotype (Browne et al., 1997). Many different dele-
tions/duplications have been reported to cause these syndromes:
class I abnormalities are larger than those of class II since they
include four genes (NIPA1, NIPA2, CYFIP1, and TUBGCP5)
and the non-coding mRNA WHAMML1 (Leblond et al., 2012;
Figure 2). Patients with class I deletions/duplications (TI) seem
to have generally more severe behavioral and psychological prob-
lems than individuals with class II deletion (TII; Figure 2). In
PWS, TI deletion also induces an increased cognitive impairment
(Buiting, 2010; Peters et al., 2012). For instance in PWS patients
carrying theTI deletion adaptative behavior, obsessive-compulsive
behaviors, reading, and visual motor integration asseements are in
general poorer if compared with PWS patients carrying a TII dele-
tion. Some researchers have analyzed onlymicrodeletions between
BP1 and BP2 (Breakpoint 1 and breakpoint 2, respectively – see
Figure 2). These patients do not have PWS and share several fea-
tures including different degrees of learning disability, delayed
motor and speech development, dysmorphisms and behavioral
problems (ADHD, autism, obsessive-compulsive behavior). Two
studies reported patients affected by schizophrenia (Stefansson
et al.,2008; Kirov et al.,2009) and inone case by epilepsia (DeKovel
et al., 2010), while another group recently published a deletion of
BP1–BP2 in two young patients affected only by ID and several
dysmorphic features (Madrigal et al., 2012). These results sug-
gest that the genes located between the BP1–BP2 breakpoints are
determining behavior and intellectual abilities (Bittel et al., 2006).
In addition, very recently, BP1–BP2 deletions have been associ-
ated to a high risk of dyslexia and dyscalculia (Stefansson et al.,
2014). The different authors proposed different conclusions con-
cerning the implication of each gene in the observed phenotype.
For instance, Bittel et al. (2006) analyzed the expression level of the
four genes in eight PWS patients carrying the BP1 deletion and
nine carrying the BP2 deletion and they compared the expression
level of each mRNA with the phenotype, concluding that NIPA1,
NIPA2, and CYFIP1 may have a greater inﬂuence on behavioral
and cognitive parameters that have been taken in consideration in
this study. In particular NIPA2, a selective Mg++ transporter, has
the greatest impact, according to these authors (Bittel et al., 2006).
Doornbos et al. (2009) proposed that while NIPA1 and CYFIP1
may be important in neurological development and thus play a
role in ID and motor/speech delays, TUBGCP5 may have a piv-
otal role in behavioral abnormalities. Interestingly, TUBGCP5 is
ubiquitously expressed with the highest level in subtalamic nuclei,
the brain region involved in ADHD and obsessive-compulsive
behavior (Doornbos et al., 2009). A reduced expression of mRNA
and protein level of CYFIP1 was reported in patients affected
by FXS and PWP. These patients displayed ASD, ID associated
to hyperphagia and obesity without cytogenetic or methylation
abnormalities at 15q11–13 (Nowiki et al., 2007). However, since
a genome-wide analysis was not performed on these patients, it
is difﬁcult to assess the impact of the perturbed expression of
CYFIP1 on their complex phenotype. The ﬁndings that in this
study ASD occurs in 10 out of 13 patients and autism in 7 out of
13 cases seems to support the implication of CYFIP1 in autism.
Conversely, Stefansson et al. (2008) supported the hypothesis that
CYFIP1 is involved in schizophrenia due also to its link to FMRP.
However, the opinion that “Fragile X behavioral abnormalities
resemble features of schizophrenia”appears strongly arguable (Ste-
fansson et al., 2008). Interestingly, recent ﬁndings pointed out a
common physiopathological mechanism in schizophrenia, autism
and ID. Indeed, these studies found an enrichement of muta-
tions causing schizophrenia in genes involved in synaptic pathways
that have been already shown to be involved in autism and ID.
In some cases, their mRNA is a target of FMRP (Fromer et al.,
2014; Purcell et al., 2014). This common etiology of neurode-
velopmental disorders could explain also a complex and variable
phenotype of deletions of the 15q11–q13 region. However, it wil be
important also to perform genome-wide analysis of these patients
to assess whether other mutations could contribute to their
phenotype.
A submicroscopic chromosome 15q11.2 duplication segregat-
ing in a pedigree with ASD was described. By expression analysis
of the genes contained in the duplicated region, CYFIP1 was sug-
gested to be candidate for involvement in the ASD phenotype
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FIGURE 2 | Schematic representation ofTI andTII deletions at the chromosomic region 15q11-q13.The BP1-BP2 deletion (including CYFIP1) is located in
15q11.2.
in this family. A 30% increase in peripheral blood mRNA
levels for the four genes present in the duplicated region in
patients, and RNA in situ hybridization on mouse embryonic
and adult brain sections revealed that two of the four genes,
CYFIP1 and NIPA1, were highly expressed in the developing
mouse brain (Ingason et al., 2011). These ﬁndings point toward
a contribution of microduplications at chromosome 15q11.2 to
autism, and highlight CYFIP1 and NIPA1 as autism risk genes
functioning in axonogenesis and synaptogenesis. Taking into
account also its functional properties, CYFIP1 is, among the
other genes located in the 15q critical region, the best candi-
date to produce an ASD (or ID) phenotype when its expression
is perturbed. This is consistent with the gene-balance hypoth-
esis, which posits that the same phenotype can arise from
under- or over-expression of dosage sensitive proteins because
they both disrupt stoichiometry of the same complex (Conrad
and Antonarakis, 2007; Darnell et al., 2011) Another exam-
ple of this situation is provided by ﬁndings showing that, as
alreadymentioned, normal synaptic plasticity and cognition occur
within an optimal range of metabotropic glutamate-receptor-
mediated protein synthesis. In this model, as shown by results
in FXS and TSC (tuberous sclerosis), deviation in either direc-
tion can cause common behavioral abnormalities (Auerbach et al.,
2011).
CYFIP2 -initially identiﬁed as a p53 dependent-apoptosis
inducible factor (Saller et al., 1999)- is localized on human
chromosome 5q33.3. This gene was not associated to human
pathologies so far. Only one case of a girl with a de novo
deletion of 5q33.3q35.1 affected by psychomotor delay, minor
facial anomalies and seizures was described, but we do not
know if CYFIP2 expression was modiﬁed by this chromosomal
abnormality (Spranger et al., 2000). By homology and analogy
with CYFIP1, the function of the two CYFIP proteins may be
very similar, as well as their role in neuronal maturation and
connectivity.
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